# Ampholipad Real-World Data in Taiwan

> **NCT03641131** · — · COMPLETED · sponsor: **Taiwan Liposome Company** · enrollment: 102 (actual)

## Conditions studied

- Aspergillus Infection
- Febrile Neutropenia
- Candida Infection
- Fungal Infection
- Cryptococcal Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03641131
- **Lead sponsor:** Taiwan Liposome Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-09
- **Primary completion:** 2019-01-02
- **Final completion:** 2019-01-08
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2021-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03641131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03641131, "Ampholipad Real-World Data in Taiwan". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03641131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*